ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the appointment of Rob Wojciechowski as Managing Director of the Consulting Practice across Europe and the Asia-Pacific region. This strategic addition to ELIQUENT’s executive team underscores the company’s commitment to continued growth within European and Asian markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031868837/en/
Rob Wojciechowski (Photo: Business Wire)
“Rob’s appointment comes at a pivotal moment for ELIQUENT. His extensive experience in managing consulting practices across diverse markets will be instrumental in expanding our footprint and enhancing our service offerings to meet the unique needs of clients in Europe and the APAC region,” said Tim Dietlin, Chief Executive Officer, ELIQUENT Life Sciences.
A seasoned life sciences executive and NED board member, Rob brings an extensive background in leadership, strategic consulting, and regional business growth. His expertise in operational delivery, building consulting practices and fostering client relationships aligns with ELIQUENT’s commitment to delivering innovative, high-quality solutions to meet the evolving needs of clients. In his role at ELIQUENT, Rob will oversee delivery and drive the expansion of the firm’s consulting services, further strengthening ELIQUENT’s global presence and delivering value-driven solutions for global clients.
Prior to joining ELIQUENT, Rob served for more than six years as Senior Vice President at Syneos Health (Previously INC Research/inVentiv Health) - a leading biopharmaceutical solutions organization that provides comprehensive, integrated services across the entire product lifecycle, from clinical trials to commercialization.
Rob also brings over 20 years of senior leadership experience, including two years as a Non-Executive Director at Sharpview Ophthalmology and key positions at INC Research, Kendle, PPD, and GSK. His roles have been focused on innovation, operational delivery and advancing global research and development across the pharmaceutical, biotechnology, and medical device sectors.
In his position at ELIQUENT, Rob will play an essential role in building and growing the firm’s full-service solutions and integrated service offerings including:
Regulatory Affairs Solutions
From the earliest phases of development, through regulatory submissions, to post-approval support, ELIQUENT’s robust blend of technical skill and clinical expertise guide companies to approval and beyond.
Pharmacovigilance & Post-Market Surveillance Solutions
With an approach that includes both strategic direction and hands-on global support, ELIQUENT’s customized pharmacovigilance services empower companies to operate with confidence.
Quality & Compliance Solutions
ELIQUENT’s highly specialized compliance experts build customized solutions that equip companies with best-in-class strategic support, technical guidance, and project-based achievements.
About ELIQUENT Life Sciences
ELIQUENT Life Sciences is the fusion of six global regulatory consultancies: Validant, Greenleaf Health, DataRevive, Oriel Stat-a-Matrix, RApport Global, and IDEC. ELIQUENT team works cross-functionally to deliver the global solutions that pharmaceutical, biotechnology, and medical device companies need to gain and maintain authorization for the products. ELIQUENT’s comprehensive services support innovators across therapeutic modalities, phase-based pathways, and major global markets. ELIQUENT’s continued growth is supported by GHO Capital, the European specialist investor in healthcare.
Learn more about ELIQUENT Life Sciences at eliquent.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031868837/en/
Contacts
Taryn Fritz Walpole
twalpole@eliquent.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Neutrogena ® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists31.10.2024 21:15:00 CET | Press Release
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establishing multi-year partnerships with Dr. Dhaval Bhanusali, renowned skincare innovator, and Dr. Muneeb Shah, the most followed dermatologist worldwide2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031619557/en/ (Photo: Business Wire) This collaboration reinforces Neutrogena®’s commitment to fusing beauty and science to deliver advanced clinical efficacy and extraordinary product experiences. It also builds on existing partnerships with a diverse network of global dermatologists who are actively involved in product development, clinical studies, and educational initiatives. Looking ahead, Neutrogena® aims to advance the science of dermatology to better address gaps in the category and help shape the future of skincare by inc
SpaceRISE selected by European Commission to build and operate the IRIS ² multi-orbit satellite constellation31.10.2024 17:18:00 CET | Press Release
SpaceRISE, the consortium comprising Eutelsat (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL), Hispasat and SES (Ticker: SESG), together with other core members, is pleased to announce it has been awarded by the European Commission to design, deliver, and operate IRIS², the European Union’s pioneering multi-orbit connectivity system. This milestone represents a crucial step towards establishing a secure, resilient, and autonomous communications infrastructure for Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031794269/en/ Interconnected Multi-Orbit System. Credit: SES IRIS² will play a transformative role in reinforcing Europe’s resilience, digital sovereignty, and low-latency connectivity for all EU Member States. This IRIS² multi-orbit satellite system is intended to enhance Europe’s ability to respond to crises, protect essential infrastructure, and bridge the digital divide. With full opera
NetApp Elevates Pamela Hennard to Chief Diversity and Inclusion Officer, Accelerating its Vision for a More Inclusive Future31.10.2024 17:00:00 CET | Press Release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced the appointment of Pamela Hennard as the new Chief Diversity and Inclusion Officer. In her expanded role, Pamela will lead NetApp's efforts to foster diversity, equity, and inclusion across the organization and within the talent acquisition process and throughout the full employee journey. Pamela Hennard has been an integral part of NetApp's success, serving as the Vice President of Global Talent Acquisition. With over 27 years of experience in human resources, Pamela brings a wealth of expertise in developing and leading high-performing teams. During Pam’s tenure at NetApp, her strategic guidance has been instrumental in setting and achieving recruitment and onboarding objectives, while also aligning with diversity, inclusion, and belonging initiatives. Throughout her career, Pamela has been a staunch advocate for diversity and inclusion, working to integrate these principles into human resources proc
Xsolla and Long Tale Games Launch Charity Campaign With Life Is Feudal to Support Games for Change31.10.2024 14:00:00 CET | Press Release
Xsolla, a global video game commerce company, has partnered with Long Tale Games to launch a charity campaign. 50% of the proceeds from the 3-month subscription package to Life is Feudal will be donatedto Games For Change. This initiative, running until December 31st, reflects Xsolla’s commitment to leveraging the power of gaming to drive positive change. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031878088/en/ (Graphic: Xsolla) The campaign offers players an exciting adventure in Life is Feudal: MMO and allows them to make a tangible impact. With half of each 3-month subscription supporting educational programs, civic engagement initiatives, and social impact projects, the campaign demonstrates how gaming can foster a better future through the power of play. Players are empowered to engage with a meaningful cause, proving that games are more than just entertainment—they are a way to support causes that matter. "Gamin
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution31.10.2024 13:00:00 CET | Press Release
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research. Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the FDA guidance for patient-centered endpoints, adaptive trial designs, and trial diversity. By unifying key trial components such as real-time patient-reported outcomes and imaging management, these bundled solutions will aid sponsors by reducing trial complexity, accelerating decision-making, and improving assessments of treatment efficacy and safety. "Oncology and vaccine trials face significant challenges in recruiting diverse patients, ensuring rapid execution, and maintaining and monitoring patient safety," said Joseph Schmidt, chief operating officer, Medidata. "By making these new bundled capabilities readily available to customers, we can deliver a solution built on Medidata’s vast experience
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom